PHR NYSE
Credit Risk of going bust: lower than 50% of companies Debt: 8.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.14 (down 99%), Phreesia, Inc. would be worth roughly what it owes.
Total debt $67.9M against a stock market value of $782.7M.
Distance to default 5.13 (Merton model): prices to 2026-10-26, balance sheet 2026-07-31, debt counted $34.4M (short-term plus half of long-term), stock volatility 61.7%; Altman Z'' -1.27. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Wilmington, DE 19803
US
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Linetsky David | P-Purchase | 35 | $9.15 | 2026-10-22 |
| Linetsky David | P-Purchase | 35 | $10.35 | 2026-10-22 |
| Hoffman Allison C | S-Sale | 6,662 | $10.08 | 2026-09-21 |
| VanDuyn Amy Beth | F-InKind | 2,876 | $10.42 | 2026-09-18 |
| Roberts Evan | F-InKind | 4,476 | $10.42 | 2026-09-18 |